Using Telemedicine to Care for Patients with Breast Cancer: A Natural Quasi-Experimental Study
- PMID: 39156945
- PMCID: PMC11326662
- DOI: 10.37029/jcas.v10i2.679
Using Telemedicine to Care for Patients with Breast Cancer: A Natural Quasi-Experimental Study
Abstract
Introduction: This investigation assessed the clinical characteristics of patients who received care through telemedicine and the clinical impact telemedicine service had on breast cancer patients in a low-income country.
Materials and methods: This natural experimental study assessed the impact of telemedicine service on cancer outcomes among breast cancer patients at Shaukat Khanum Memorial Trust (SKMT), Pakistan, between January 1st, 2018, to December 31st, 2022. The study group (hybrid group) consisted of patients that had both face-to-face and telemedicine appointments, and the control group (physical group) included patients with only face-to-face encounters.
Results: A total of 3,205 patients were included in the analysis. Among those included in the analysis, 3,188 (99.5 %) were females, and the mean age of the cohort was 48.10 ± 11.94 years. Statistically significant differences were observed between the two groups in age, demographic distribution, disease stage, average number of emergency room visits, mean length of stay in the Intensive care unit, and the final patient status (alive at the end of observation period). However, the binary logistic regression model (forward-LR) suggested that the final patient outcome was related to disease relapse, COVID-19 infection, and age.
Conclusion: Telemedicine clinics, when conducted in parallel with physical clinics (hybrid setup), are safe and have a clinical impact similar to having just physical encounters among breast cancer patients in a low-income country.
Keywords: Breast cancer; low-middle income countries (LMIC); oncology; telehealth; telemedicine.
Copyright: © 2024 Nasir KS, et al.
Conflict of interest statement
The author(s) declare(s) that there are no conflict of interest.
Figures
Similar articles
-
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0. Trials. 2021. PMID: 33810796 Free PMC article.
-
Positive impact of the pandemic: the effect of post-COVID-19 virtual visit implementation on departmental efficiency and patient satisfaction in a quaternary care center.Neurosurg Focus. 2022 Jun;52(6):E10. doi: 10.3171/2022.3.FOCUS2243. Neurosurg Focus. 2022. PMID: 35921181
-
Implementation of a Hybrid Care Model for Telemedicine-based Cancer Pain Management at the Cancer Center of Naples, Italy: A Cohort Study.In Vivo. 2023 Jan-Feb;37(1):385-392. doi: 10.21873/invivo.13090. In Vivo. 2023. PMID: 36593040 Free PMC article.
-
Telephone interventions for symptom management in adults with cancer.Cochrane Database Syst Rev. 2020 Jun 2;6(6):CD007568. doi: 10.1002/14651858.CD007568.pub2. Cochrane Database Syst Rev. 2020. PMID: 32483832 Free PMC article.
-
Implementation of a telemedicine service to provide skin cancer care in a tertiary plastic surgery unit during COVID-19 - a comprehensive review.J Plast Reconstr Aesthet Surg. 2022 Sep;75(9):3608-3615. doi: 10.1016/j.bjps.2022.04.031. Epub 2022 Apr 25. J Plast Reconstr Aesthet Surg. 2022. PMID: 35739023 Free PMC article. Review.
References
-
- Sirintrapun SJ, Lopez AM. Telemedicine in cancer care. Am Soc Clin Oncol Educ Book. 2018;38:540–5. - PubMed
-
- Roque K, Ruiz R, Otoya-Fernandez I, Galarreta J, Vidaurre T, de Mello RA, et al. The impact of telemedicine on cancer care:Real-world experience from a Peruvian institute during the COVID-19 pandemic. Future Oncol. 2022;18:3501–8. - PubMed
LinkOut - more resources
Full Text Sources